Abstract
Biotransfomation has been increasingly utilized as a tool to generate pharmaceutical lead compounds from natural products in recent years. A wide variety of natural pruducts including aromatics, steroids, alkaloids, coumarins, flavonoids and terpenoids can be biotransformed by fungi, yeasts, bacteria, plant cells and enzymes derived from these sources. The biochemical reactions occurring in microorganisms and plant cells are typically regio- and stereo-selective, which is difficult to be achieved by chemical methods. In this review we describe important biotransformations used for the generation of lead compounds with pharmaceutical utilities and further structural diversification of complex natural products, especially those from traditional Chinese medicines. Such approach will ultimately benefit the advancement of biotransformation and potential therapeutics.
Keywords: Biotransformation, Natural product, Bioactive compound, Enzyme catalysis, Drug discovery, Terpenoids, Alkaloids, Steroids
Current Organic Chemistry
Title: Biotransformation of Bioactive Natural Products for Pharmaceutical Lead Compounds
Volume: 14 Issue: 14
Author(s): Ji-Hua Liu and Bo-Yang Yu
Affiliation:
Keywords: Biotransformation, Natural product, Bioactive compound, Enzyme catalysis, Drug discovery, Terpenoids, Alkaloids, Steroids
Abstract: Biotransfomation has been increasingly utilized as a tool to generate pharmaceutical lead compounds from natural products in recent years. A wide variety of natural pruducts including aromatics, steroids, alkaloids, coumarins, flavonoids and terpenoids can be biotransformed by fungi, yeasts, bacteria, plant cells and enzymes derived from these sources. The biochemical reactions occurring in microorganisms and plant cells are typically regio- and stereo-selective, which is difficult to be achieved by chemical methods. In this review we describe important biotransformations used for the generation of lead compounds with pharmaceutical utilities and further structural diversification of complex natural products, especially those from traditional Chinese medicines. Such approach will ultimately benefit the advancement of biotransformation and potential therapeutics.
Export Options
About this article
Cite this article as:
Liu Ji-Hua and Yu Bo-Yang, Biotransformation of Bioactive Natural Products for Pharmaceutical Lead Compounds, Current Organic Chemistry 2010; 14 (14) . https://dx.doi.org/10.2174/138527210791616786
DOI https://dx.doi.org/10.2174/138527210791616786 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cardiovascular Risk Factors in Chronic Inflammatory Rheumatic Diseases: Modern Assessment and Diagnosis
Current Vascular Pharmacology Growth Restriction: Etiology, Maternal and Neonatal Outcome. A Review
Current Women`s Health Reviews The Role of Adipokines in Hypertension and Cardiovascular Disease
Current Hypertension Reviews Statins in Stroke
Current Medicinal Chemistry Editorial: Time for Earlier and More Intensive Preventive Therapy
Current Vascular Pharmacology Active Metabolites Resulting from Decarboxylation, Reduction and Ester Hydrolysis of Parent Drugs
Current Drug Metabolism Editorial [Hot Topic : Current Practice and trends in echocardiography in Critical Care, Anesthesiology and Emergency Medicine (Guest Editor: Paulo Marcelino)]
Current Cardiology Reviews Management of Cardiogenic Shock due to Thyrotoxicosis: A Systematic Literature Review
Current Cardiology Reviews Pharmacological and Biological Activities of Xanthones
Anti-Infective Agents in Medicinal Chemistry Editorial [Hot Topic: Novel Pharmacological Therapies for Cardiac Hypertrophy and Heart Failure (Executive Guest Editor: Peter M. Kang)]
Current Pharmaceutical Design Novel Biomarkers Assessing the Calcium Deposition in Coronary Artery Disease
Current Medicinal Chemistry A Review of Hypertension Management in Atrial Fibrillation
Current Hypertension Reviews Intrinsically Fluorescent Base-Discriminating Nucleoside Analogs
Mini-Reviews in Organic Chemistry Molecular Determinants of Vascular Calcification: A Bench to Bedside View
Current Molecular Medicine Monocyte Cyclooxygenase-2 Activity: A New Therapeutic Target for Atherosclerosis?
Current Drug Targets - Cardiovascular & Hematological Disorders Treatment and Response to Statins: Gender-related Differences
Current Medicinal Chemistry Chalcones as Versatile Synthons for the Synthesis of 5- and 6-membered Nitrogen Heterocycles
Current Organic Chemistry Ranolazine and its Antiarrhythmic Actions
Cardiovascular & Hematological Agents in Medicinal Chemistry Taste and Hypertension in Humans: Targeting Cardiovascular Disease
Current Pharmaceutical Design MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases
Current Drug Targets